Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to low-income countries. Research ethics are discussed.
TSMC’s CEO said ‘no shortcuts’ four times when analysts pushed on competition. Supply stays tight through 2027 – the AI boom has a physical ceiling running through Taiwan
A razor-thin crescent moon will glow beside brilliant Venus on Saturday, April 18 and Sunday, April 19, one of spring’s most beautiful and easy-to-see sky events.
Covert real-time coaching of witnesses and is now cheap, hidden and easy. Every legal proceeding that runs on live testimony is exposed.
After watching engineers burn out from fixing late-night outages, Resolve AI CEO Spiros Xanthos is developing AI systems to ease the burden of being on call, backed by a new $40 million funding round.
Paris-based Mistral wanted to develop a top-tier AI model to rival OpenAI and Anthropic. That didn’t work out. But it turns out lots of folks don’t care if the AI is bleeding edge – as long as it wasn’t made in America or China.
Forbes’ AI 50 list spotlights the most promising privately held companies applying artificial intelligence to solve real-world challenges.
AI’s New Training Data: Your Old Work Slacks And Emails
An iPhone exploit allows bad actors to conduct high-value transactions from your locked phone. Here’s the simple step you need to take to prevent it.
Garmin has a new watch for aviators, one that adds InReach communication tech to the pilot watch line. But it does not come cheap.